Table 1.
Patient Characteristics
| Characteristics (N=62) | n (%) | |
|---|---|---|
| Age (years) |
|
|
| Median (range) |
66 (37–93) |
|
| Sex |
|
|
| Female |
|
32 (52) |
| Male |
|
30 (48) |
| Karnowsky PS |
|
|
| Median (range) |
40 (20–80) |
|
| ≤ 40 |
|
32 (52) |
| ≥ 50 |
|
30 (48) |
| Site* |
|
|
| Bladder |
|
10 (16) |
| Lung (NSCLC) |
|
9 (15) |
| Endometrial |
|
8 (13) |
| Prostate |
|
6 (10) |
| Cervical |
|
6 (10) |
| Gastric |
|
6 (10) |
| Ovarial |
|
6 (10) |
| Colorectal |
|
3 (5) |
| Others# |
|
8 (13) |
|
Histology+ |
|
|
| Adenocarcinoma |
|
38 (65) |
| Squamous cell carcinoma |
|
6 (10) |
| Transitional cell carcinoma |
|
9 (15) |
|
Others |
|
6 (10) |
|
Tumor-classification+ |
|
|
| T0 |
|
2 (3) |
| T3 |
|
2 (3) |
| T4 |
|
55 (94) |
| Metastasis+ |
|
|
| No |
|
1 (2) |
| Yes |
|
52 (88) |
| Unknown |
|
6 (10) |
|
Liver metastasis+ |
|
|
| No |
|
43 (73) |
| Yes |
|
16 (27) |
|
Bleeding Site+ |
|
|
| Primary tumor |
|
48 (81) |
| Metastasis |
|
11 (19) |
| Symptom |
|
|
| Vaginal bleeding |
|
19 (31) |
| Hematuria |
|
17 (27) |
| Hemoptysis |
|
10 (16) |
| Others |
|
16 (26) |
| First diagnosis to hRT (months) |
|
|
| Median (range) | 11 (0.3-183) |
Abbreviations: PS=performance status; NSCLC=non-small+ cell lung cancer; hRT=hemostatic radiotherapy; *Site of the primary tumor; # including esophageal (n=2), sarcoma (n=1), multiple myeloma (n=1), kidney cancer (n=1), non-hodgkin lymphoma (n=1), breast cancer (n=1) and pseudomyxoma peritonei (n=1)+. Three patients were not applicable having stage IV non-hodgkin lymphoma according to Ann Arbor (n=1) or stage III multiple myeloma according to Durie and Salmon (n=1) or benign pseudomyxoma peritonei (n=59).